- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 01.09. | FDA approves Eisai and Biogen's Leqembi Iqlik BLA for early Alzheimer's | ||
| 29.08. | EMA grants orphan designation to Aldeyra's ADX-2191 for vitreoretinal lymphoma | ||
| 28.08. | Leal Therapeutics raises $30m in Series A funding for neuro-metabolic therapies | ||
| 26.08. | FDA expands Amgen's Repatha use to adults at risk of cardiovascular events | ||
| 25.08. | Piramal Pharma opens oral solid dosage suite in Pennsylvania, US | ||
| 22.08. | BeOne Medicines receives EC approval for Brukinsa tablet formulation | ||
| 21.08. | BMS Secures Health Canada approval for dual immunotherapy | ||
| 20.08. | Santhera signs deal with Uniphar for GCC distribution of Agamree | ||
| 19.08. | FDA grants orphan drug status to Soligenix's dusquetide | ||
| 18.08. | Halda receives FDA fast track status for HLD-0915 to treat prostate cancer | ||
| 14.08. | BioDlink's bevacizumab receives marketing approval in Colombia, Pakistan | ||
| 13.08. | Southern Research opens new biotech centre in Alabama | ||
| 12.08. | FDA gives approval to Viatris for Iron Sucrose Injection | ||
| 11.08. | Annexon announces EMA selection of vonaprument for PDC pilot participation | ||
| 08.08. | Intas Pharmaceuticals acquires Udenyca from Coherus BioSciences | ||
| 07.08. | Cingulate submits NDA for CTx-1301 for ADHD treatment | ||
| 06.08. | Kye Pharmaceuticals gains Health Canada approval for Dyanavel XR to treat ADHD | ||
| 05.08. | Minaris Advanced Therapies opens new manufacturing facility in Germany | ||
| 04.08. | Turbine and MSD aim to advance cancer treatment through AI simulations | ||
| 31.07. | Vivace Therapeutics' VT3989 for mesothelioma gains FDA Orphan Drug Designation | ||
| 30.07. | Diorasis, Northway Biotech team up on glaucoma gene therapy development | ||
| 29.07. | AstraZeneca's Imfinzi gains FDA priority review | ||
| 28.07. | CHMP endorses Pfizer-BioNTech's updated Covid-19 vaccine | ||
| 25.07. | Candel Therapeutics' CAN-2409 gains EMA orphan designation | ||
| 24.07. | LEO Pharma's Anzupgo cream receives FDA approval for chronic hand eczema |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .